$94.17
▲ +0.0% Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 3
● 22
▼ 0
Medtronic executives to speak at upcoming investor conferences
Daiwa Securities Adjusts Price Target on Medtronic to $108 From $95, Maintains Buy Rating
4 Reasons to Buy Medtronic Stock Like There's No Tomorrow
Overview
52-week range
$73
$106
63% of range
Avg surprise (last 2)
+2.5%
Avg reaction (last 1)
-2.3%
0% positive
Latest IV / EM
31%
EM ±1.3% · $93 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri Jan 23, 2026 | Jan 2026 | $0.89 | — | — | — | — | financials |
| Fri Oct 24, 2025 | Oct 2025 | $1.07 | — | — | — | — | financials |
| Tue Aug 19, 2025 | Jul/2025 | $1.26 | $1.23 | +2.4% | — | — | earnings |
| Wed May 21, 2025 | Apr/2025 | $1.62 | $1.58 | +2.5% | — | -2.3% | earnings |
| Fri Jan 24, 2025 | Jan 2025 | $1.01 | — | — | — | — | financials |
| Fri Oct 25, 2024 | Oct 2024 | $0.99 | — | — | — | — | financials |
| Fri Jul 26, 2024 | Jul 2024 | $0.80 | — | — | — | — | financials |
| Fri Jan 26, 2024 | Jan 2024 | $0.99 | — | — | — | — | financials |
| Fri Oct 27, 2023 | Oct 2023 | $0.68 | — | — | — | — | financials |
| Fri Jul 28, 2023 | Jul 2023 | $0.59 | — | — | — | — | financials |
| Fri Jan 27, 2023 | Jan 2023 | $0.92 | — | — | — | — | financials |
| Fri Oct 28, 2022 | Oct 2022 | $0.32 | — | — | — | — | financials |
| Fri Jul 29, 2022 | Jul 2022 | $0.70 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.02B | $8.96B | $8.58B | — | $8.29B | $8.40B | $7.92B | — |
| Cost of revenue | $3.26B | $3.06B | $3.00B | — | $2.78B | $2.95B | $2.76B | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.46B | $1.69B | $1.45B | — | $1.65B | $1.59B | $1.28B | — |
| Net income | $1.14B | $1.38B | $1.05B | — | $1.29B | $1.28B | $1.05B | — |
| EPS (diluted) | $0.89 | $1.07 | $0.81 | — | $1.01 | $0.99 | $0.80 | — |
Balance sheet (quarterly)
| Metric | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.15B | $1.28B | $1.27B | $2.22B | $1.24B | $1.39B | $1.31B | $1.28B |
| Inventory | $6.31B | $6.16B | $5.89B | $5.48B | $5.61B | $5.48B | $5.41B | $5.22B |
| Total current assets | $24.07B | $24.00B | $23.22B | $23.81B | $22.51B | $22.44B | $21.95B | $21.93B |
| Total assets | $91.48B | $91.35B | $90.97B | $91.68B | $89.97B | $90.04B | $89.75B | $89.98B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $42.29B | $42.49B | $42.84B | $43.42B | $40.36B | $41.33B | $41.59B | $39.56B |
| Total equity | $48.98B | $48.86B | $48.13B | $48.02B | $49.62B | $48.72B | $48.16B | $50.21B |